Seegene, 'Through export adjustments of diagnostic kits, Seegene's estimates are becoming more realistic' stock price 113,600 won (6.87%)

As of 10:32 AM on the 8th, Seegene is trading at 113,600 KRW, up 6.87% from the previous day. The trading volume is 1,573,434 shares, which is approximately 196.39% of the previous day's volume. Seegene is known as a developer, manufacturer, and seller of molecular diagnostic reagents.

On June 3rd, Minjeong Seon, a researcher at Hana Financial Investment, stated, "As governments around the world are expected to stockpile COVID-19 diagnostic kits, exports of COVID-19 diagnostic kits are also expected to exceed second-quarter export amounts in the second half of this year. From the second half of 2022, as the COVID-19 virus outbreak subsides, COVID-19 diagnostic kits are expected to contract by about 30% compared to the previous year. However, as Seegene’s equipment is somewhat installed in clinical pathology centers, the overall growth trend of Seegene’s other reagent sales is expected to maintain a significant increase." The target price for Seegene was announced as 150,000 KRW.

Over the past five days, individual investors have net purchased 451,381 shares of Seegene, while foreign investors and institutions have net sold 160,695 shares and 279,600 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.